| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Yi Guan CEO | XSHE Exchange | CNE100001WT7 ISIN |
| CN Country | 5,727 Employees | 17 Jul 2026 Last Dividend | 18 Apr 2018 Last Split | - IPO Date |
Sunflower Pharmaceutical Group Co.,Ltd, established in 2005 and headquartered in Harbin, China, specializes in the arena of pharmaceuticals with a focus on the development, manufacturing, and marketing of Chinese patent medicines both domestically and on a global scale. The company has diversified its portfolio to include the production of chemical and biological medicines along with health care products, catering to the wide-ranging needs of its customer base. Its international presence is marked by its commitment to providing top-tier medicines and healthcare products across various segments.
Sunflower Pharmaceutical Group Co.,Ltd offers a broad array of products and services across different therapeutic areas and healthcare needs, such as:
These products are marketed under the Sunflower and Little Sunflower brands, reflecting the company’s dedication to quality and customer trust in its extensive range of healthcare solutions.